Dextromethorphan + Phenylephrine + Triprolidine

Introduction

Dextromethorphan, phenylephrine, and triprolidine are combined in some over-the-counter (OTC) cough and cold medications to address multiple symptoms associated with colds and allergies. This combination aims to provide relief from cough, nasal congestion, and allergic reactions through their complementary actions.

Uses

This combination is used for:

• Relieving cough due to minor throat and bronchial irritation.
• Alleviating nasal congestion associated with colds or allergies.
• Reducing symptoms of allergic rhinitis, such as sneezing and runny nose.

Mechanism of Action

The three active ingredients work through different mechanisms:

• Dextromethorphan is a cough suppressant that works on the central nervous system. It acts on the cough center in the brain to reduce the urge to cough.
• Phenylephrine is a decongestant that works by constricting blood vessels in the nasal passages, reducing swelling and congestion.
• Triprolidine is an antihistamine that blocks histamine receptors to reduce allergy symptoms like sneezing, itching, and runny nose.

How Long Does It Take to Work?

The onset of action varies by component:

• Dextromethorphan typically starts to work within 30 minutes to 1 hour, providing cough relief.
• Phenylephrine generally begins to relieve nasal congestion within 30 minutes to 1 hour.
• Triprolidine usually starts to reduce allergy symptoms within 1 to 2 hours.

Absorption

Each component is absorbed differently:

• Dextromethorphan is absorbed quickly from the gastrointestinal tract.
• Phenylephrine is also absorbed from the GI tract but has a lower bioavailability due to extensive first-pass metabolism.
• Triprolidine is well-absorbed following oral administration.

Route of Elimination

The elimination routes are:

• Dextromethorphan is metabolized primarily in the liver and excreted via the kidneys.
• Phenylephrine is metabolized in the liver and also excreted via the kidneys.
• Triprolidine undergoes hepatic metabolism and is excreted in the urine.

Dosage

Dosage varies based on the specific product formulation, but general guidelines are:

• Dextromethorphan: Typically 10-20 mg every 4 to 6 hours, not exceeding 120 mg per day.
• Phenylephrine: Usually 10 mg every 4 hours as needed, not exceeding 60 mg per day.
• Triprolidine: Commonly 2.5-5 mg every 4 to 6 hours, not exceeding 20 mg per day.

Administration

Administer the product orally:

• Take the medication with or without food, as directed.
• Measure the dose using the provided dosing device or as directed by a healthcare provider.

Side Effects

Possible side effects include:

• Dextromethorphan: Drowsiness, dizziness, nausea, and, rarely, hallucinations.
• Phenylephrine: Increased blood pressure, headache, dizziness, and insomnia.
• Triprolidine: Drowsiness, dry mouth, dizziness, and blurred vision.

Toxicity

Potential toxicity may occur with overdose:

• Dextromethorphan: Excessive doses can lead to severe drowsiness, hallucinations, and CNS effects.
• Phenylephrine: Overdose can cause severe hypertension, headache, and anxiety.
• Triprolidine: High doses may lead to severe anticholinergic effects like confusion, agitation, and dry mouth.

Precautions

Precautions include:

• Avoid use in individuals with severe hypertension, cardiovascular disease, or severe liver disease.
• Use caution if you have a history of asthma or respiratory conditions.
• Consult a healthcare provider before using this medication if pregnant, breastfeeding, or taking other medications.

Interaction

Interactions with other medications may include:

• Other CNS depressants can enhance drowsiness caused by dextromethorphan and triprolidine.
• Phenylephrine may interact with medications for hypertension or other decongestants, leading to increased blood pressure.

Disease Interaction

Use with caution in individuals with:

• Hypertension or cardiovascular conditions due to phenylephrine's effects on blood pressure.
• Respiratory conditions, as triprolidine may cause increased mucus production or sedation.
• Liver or kidney impairment, as these conditions may affect the metabolism and elimination of the drug components.

Drug Interaction

Drug interactions to be aware of include:

• CNS depressants (e.g., alcohol, benzodiazepines) can enhance the sedative effects of dextromethorphan and triprolidine.
• MAO inhibitors may interact with dextromethorphan, leading to serotonin syndrome.
• Other decongestants or antihistamines may increase side effects or lead to excessive stimulation or sedation.

Food Interactions

Food interactions are minimal. However, consuming large amounts of alcohol or caffeine can potentially enhance side effects like drowsiness or nervousness. It is generally safe to take the medication with or without food.

Pregnancy Use

Consult a healthcare provider before using this combination during pregnancy. While dextromethorphan, phenylephrine, and triprolidine are used in various OTC products, their safety during pregnancy is not well-established, and risks should be assessed by a healthcare provider.

Lactation Use

Consult a healthcare provider before using this medication while breastfeeding. Small amounts of these compounds may pass into breast milk, and safety should be evaluated based on individual circumstances.

Acute Overdose

In case of acute overdose:

• Dextromethorphan: Symptoms may include severe drowsiness, hallucinations, and seizures.
• Phenylephrine: Overdose may cause severe hypertension, cardiovascular issues, and severe headache.
• Triprolidine: Symptoms may include severe anticholinergic effects such as confusion, severe drowsiness, and urinary retention.

Contraindication

Contraindications include:

• Known hypersensitivity or allergic reactions to any of the active ingredients.
• Severe hypertension or severe cardiovascular disease for phenylephrine use.
• Severe liver or kidney impairment due to potential complications with metabolism and clearance.

Use Direction

For proper use:

• Take the medication as directed on the label or by a healthcare provider.
• Measure doses carefully using the provided device or instructions.
• Do not exceed the recommended dosage.

Storage Conditions

Store the product in a cool, dry place at room temperature (15-30°C or 59-86°F). Keep the container tightly closed and out of reach of children. Avoid exposure to moisture and direct sunlight.

Volume of Distribution

The volume of distribution is not typically specified for combination cough and cold products. Each component is distributed throughout the body differently, with dextromethorphan, phenylephrine, and triprolidine primarily exerting their effects at the site of action.

Half Life

Half-lives of the components are:

• Dextromethorphan: Approximately 2-4 hours.
• Phenylephrine: Approximately 2-3 hours.
• Triprolidine: Approximately 2-4 hours.

Clearance

Clearance of these components generally involves:

• Dextromethorphan: Primarily metabolized in the liver and cleared via the kidneys.
• Phenylephrine: Metabolized in the liver and cleared via the kidneys.
• Triprolidine: Metabolized in the liver and excreted in the urine.